Sherritt M.A., Gardner J., Elliott S.L., Schmidt C., Purdie D., Deliyannis G., Heath W.R., and Suhrbier A. 2000. Effect of pre-existing cytotoxic T lymphocytes on therapeutic vaccines. A.J. Ramsey, S.J. Kent, R.A. Strugnell, A. Suhrbier, S.A. Thomson and I. Ramshaw. 1999. Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity. An HLA A2 Polyepitope Vaccine for Melanoma Immunotherapy.
T lymphocytes protect against retroviral challenge.
Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. 1717-1723 A. Suhrbier. Multi-epitope DNA vaccines. X.Y. Mo, R. Tripp, P. C. Doherty, D. J. Moss, A. Suhrbier. The persisting infection probably maintains an inflammatory response which recruits more macrophages into the joint where they become infected.